期刊名称：AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
 |
The American Journal of Respiratory and Critical Care Medicine is one of the official journals of the American Thoracic Society. Articles published in this journal consist predominantly of original research either clinically based or of a basic science nature. Papers that are solely or predominantly based in cell and molecular biology are published in the companion journal of the American Thoracic Society, the American Journal of Respiratory Cell and Molecular Biology. The Journal also seeks to publish outstanding review articles on areas of interest in several forms. The State-of-the-Art review is a treatise usually covering a broad field that brings bench research to the bedside. Shorter reviews are published as Clinical Commentaries or Pulmonary Perspectives. These are generally focused in a more limited area and advance a concerted opinion about care for a specific process. Case Reports of exceptional merit also are published in the journal.
A recent trend and future direction of the journal has been to include debates of a topical nature on issues of importance in pulmonary and critical care medicine and to the membership of the society. Other recent changes have included encompassing works from the field of critical care medicine and the extension of the editorial governing of journal policy to colleagues outside of the United States of America. The focus and direction of the Journal is to establish an international forum for state-of-the-art respiratory and critical care medicine.
HISTORY
The first issue of the American Journal of Respiratory and Critical Care Medicine was published in March 1917 as the American Review of Tuberculosis. Since then there have been several title changes. In 1953 a subtitle was added, "A Journal of Pulmonary Diseases." In 1955 the title became the American Review of Respiratory Diseases, and in 1965 the American Review of Respiratory Disease. Finally in 1994 the Journal became the American Journal of Respiratory and Critical Care Medicine. Recent editors included John F. Murray, MD (1973-1980), Gareth Green, MD (1980-1985), Reuben Cherniack, MD (1985-1989), Robert A. Klocke, MD (1989-1994), and Alan R. Leff, MD (1994-1999). The current Editor, Martin J. Tobin, M.D., is Director of the Division of Pulmonary and Critical Care Medicine at Loyola University Medical Center and Hines VA Hospital in Chicago, Illinois.
AIMS AND SCOPE
The AJRCCM focuses on human biology and disease, as well as animal and in vitro studies that contribute to the understanding of pathophysiology and treatment of diseases that affect the respiratory system and critically ill patients.
SCIENCE CITATION INDEX RATING
AJRCCM ranks 1st in terms of frequency of citation among 20 journals listed under Respiratory System in Science Citation Index. |
Instructions to Authors
SUBMISSION OF MANUSCRIPTS
The preferred mode for submitting NEW MANUSCRIPTS to the American Journal of Respiratory and Critical Care Medicine is online. To submit your manuscript, please go to http://ATSjournals.manuscriptcentral.com. Complete instructions for online submission are located on this website. Technical support is available from Monday through Friday, 9:00 am to 5:00 pm, Eastern Standard Time, at 212-315-8638 or by e-mail (fling@thoracic.org). Manuscripts that do not conform to guidelines will be delayed in processing.
Within 24 hours after completing the online submission of the manuscript, send the following to our Peer Review Office:
All correspondence related to manuscripts should be addressed to:
Martin J. Tobin, M.D., Editor
American Journal of Respiratory and Critical Care Medicine
ATS Peer Review Office
61 Broadway
New York, NY 10006-2755
Tel: (212) 315-8625/8626
FAX: (212) 315-8613
Since May 1, 2002, all manuscripts are to be submitted to the American Journal of Respiratory and Critical Care Medicine online. Exceptions will be granted by the Editor only when the Corresponding Author presents a convincing case for why the online system cannot be used. Instructions on submitting a manuscript in hard-copy format will be provided when permission is granted.
Online submission of Revised Manuscripts will require also that a clean version of the uploaded revision (in WORD) on a 3.5" HD diskette and two sets of hard, publication-quality illustrations be mailed to the Peer Review Office.
Manuscripts are acknowledged by ScholarOne upon receipt. Submission, Copyright and Disclosure of Financial Interest Forms are not acknowledged by the Peer Review Office upon receipt, but you will be queried if they are not received. When inquiring about a manuscript, refer to the number assigned the manuscript. Inquiries will be accepted from the designated Corresponding Author only.
SUBMISSION FORM
Authors MUST submit a completed Manuscript Submission Form at the time of submission, which can be downloaded from http://www.thoracic.org/publications/ajrccm/ajrccmsubform.doc. This form can also be obtained from the Journal's Peer Review Office; the form may be photocopied. The Manuscript Submission Form should be uploaded with the manuscript submission or FAXed to the Peer Review Office (212-315-8613) within 24 hours after submission of the manuscript. On behalf of all authors, the Corresponding Author must sign the Manuscript Submission Form. On this form, list the name, address, e-mail address, FAX number, and telephone number of the Corresponding Author who submitted the manuscript. This individual can be a different Corresponding Author from the contact author on the Title Page of the manuscript.
The omission of the Manuscript Submission Form and the failure to comply with submission policies will delay processing of a manuscript.
By virtue of submitting a manuscript for consideration to the American Journal of Respiratory and Critical Care Medicine, the authors certify that the material in the manuscript has not been published and is not being considered for publication elsewhere, including publicly accessible websites or e-print servers. On the Manuscript Submission Form, authors must certify that no part of the research presented has been funded by tobacco industry sources. If any data are derived from subjects or animals of a previous report, this must be stated explicitly in a cover letter in the "Author Comments" area on the ScholarOne website as well as in the manuscript. When some or all of the dataset for a submitted manuscript were also used for the results in another manuscript, this point must be stated explicitly in the "Author Comments" area even when the results presented in the submitted manuscript do not overlap with the results presented in the other manuscript.
Submission of a manuscript indicates tacit acknowledgment that all authors have made significant contributions to the study, have read and approved the manuscript, and are fully responsible for its content. Any change in authorship following the original submission must be justified and agreed to in writing by the affected author(s). The American Journal of Respiratory and Critical Care Medicine allows the designation of more than a single first author when two authors have made equal contributions to a study.
An Assignment of Copyright Form, signed by all authors, must also accompany the manuscript. This form can be downloaded from http://www.thoracic.org/publications/ajrccm/bluecopy.asp and it can also be obtained from the Peer Review Office of the Journal. The form may be photocopied, and the signatures of authors can be on several different forms. Because we must receive ORIGINAL signatures, these forms must be MAILED to the Peer Review Office. A fax or electronic transmission will not satisfy.
Authors may list three to five reviewers (include e-mail address, FAX number, and telephone number) they believe are qualified to review the paper. Suggested reviewers should not have been collaborators or coauthors within the previous three years, nor should they have provided substantial advice or critique of the submitted manuscript. Authors may also request disqualification of up to two reviewers with potential conflict of interest.
REVISIONS
If a manuscript was originally submitted online, the authors must also send the Revision online. We will not process the Revision if it is submitted in hard copy format. If a manuscript was originally submitted in hard-copy format, the authors must also send the Revision in hard-copy format to the Peer Review Office. We will not process the revision if it is submitted online.
Authors MUST submit a completed Manuscript Submission Form with all revisions. In addition, authors must upload a "marked-up" copy of the preceding version of the manuscript. (Authors who originally submitted their manuscript hard copy must mail both a "marked-up" and a clean version of the Revision.)
The online system does not permit revisions directly on the version of the manuscript originally submitted to Manuscript Central. Instead, authors should revise their manuscript using a word processor and then resubmit the revised version, ensuring that it is marked R1. Authors need to submit two online versions of the revised manuscript: a clean version and a "marked-up" version. To create the "marked-up" version, authors should use a red font instead of a black font to indicate the portions of the manuscript that have been changed. The "marked-up" version should be placed first and the clean version be attached behind it.
If supplementary material was initially submitted for consideration for posting in the Online Repository, the material needs to be included again when a revised manuscript is being submitted.
If a revision of an Original Article is not received within six (6) months from the last decision letter of an Associate Editor, the Journal will assume that the authors have withdrawn the manuscript from further consideration. In cases where substantial new data are required, extensions may be granted at the Editors' discretion. The time limit for receipt of revisions of a Featured Article, such as a State-of-the-Art Review Article, Clinical Commentary, Pulmonary Perspective, and Critical Care Perspective, is three (3) months.
When submitting a revised manuscript, either online or in hard-copy format, authors must mail a clean copy of the manuscript on a 3.5 inch high-density diskette, a clean copy of the Online Data Supplement on a separate disk and two sets of publication-quality illustrations (laser-printed hard copy is acceptable). These items must be mailed to the Peer Review Office.
DISK SUBMISSION
Authors must submit the REVISED version of a manuscript, irrespective of whether the first submission was online or in hard-copy format, on disk accompanied by two hard-copies of publication-quality illustrations. On the disk's label, specify the file name and operating system. Only Microsoft WORD files are acceptable.
PAGE CHARGES
All manuscripts for original articles, brief communications, and case reports will be subject to page charges at the rate of $75 per printed page. Authors will be billed for the charges
CONFLICT OF INTEREST
When submitting a manuscript to the American Journal of Respiratory and Critical Care Medicine, all authors are required to state explicitly whether they have or do not have any financial relationship with a biotechnology manufacturer, pharmaceutical manufacturer, or other commercial entity that has an interest in the subject matter or materials discussed in the manuscript.
A conflict of interest is defined a set of conditions in which professional judgment concerning a primary interest, such as the validity of research, might be influenced by a secondary interest, such as financial gain. The secondary interest is usually not illegitimate in itself, but it becomes a problem when it eclipses the primary interest. With this definition, a conflict of interest is a condition, not a behavior. It is determined by circumstances, not by outcome. A conflict exists not only when judgment has been clearly influenced. It also exists when judgment might be influenced or might be perceived to be influenced. That is, a conflict exists before any actual breach of trust, and irrespective of whether a breach of trust actually occurs.
The Journal assumes that every author submitting a manuscript has some type of conflict of interest. The Journal's policy on disclosure applies only to authors who have financial relationships with manufacturers that have an interest in the subject matter of their manuscript.
At the time of submitting an original scientific manuscript, review article, editorial, or letter to the editor to the Journal, each and every author is required to complete a "Disclosure of Financial Interest" form. After May 1, 2003, all authors submitting a revised manuscript to the Journal are required to complete the disclosure form if it was not included with the original submission. On the disclosure form, authors are required to provide explicit answers to a series of concrete questions on financial relationships. In addition, each author is required to write a statement of financial disclosure related to him or herself (sample statement is provided on the form). When writing the statement for publication in the Journal, authors can choose to list the precise dollar amount received from a manufacturer or make a general statement; examples of both types of statement are provided on the disclosure form.
The Journal's criteria for a financial relationship is broad in scope. For example, if an author has received money from a company that manufactures a bronchodilator and the manuscripts deals with any aspect of airway biology or disease, the author is required to disclose receipt of the money. Likewise, an author who has received money from a company that manufactures or markets mechanical ventilators and the manuscripts deals with any aspect of mechanical ventilation, the author is required to disclose receipt of the money. All such financial relationship must be listed in the table on "Personal Financial Interests" (page 1 of the form for Disclosure of Financial Interest) and the information must also be included in the Conflict of Interest Statement (page 2 of the form for Disclosure of Financial Interest) that each author writes for subsequent publication in the Journal.
All of the forms must be uploaded at the time of manuscript submission. The form will be accessible to reviewers online during peer review. Once a manuscript has been accepted, the form will be deleted and a disclosure footnote will be published in the article.
The Journal requires authors to list the receipt of more than $5,000 per company per year in any one of the three years preceding submission of a manuscript. The Journal's policy on personal financial interests also embraces money received in the names of the children, spouse, or partner (i.e., life companion) of an author. In computing the amount received from one company in one year, authors are required to combine consulting fees, advisory board fees, writing fees, honoraria, travel expenses, hotel expenses, gifts, and other in-kind compensation. An author who does not know the precise amount of money paid by a commercial entity for hotel expenses and travel to a meeting is requested to make a best estimate. Because the threshold of $5,000 is necessarily arbitrary, the Journal also encourages authors to list lesser amounts. If authors are uncertain about how much to disclose, it is best to err on the side of providing comprehensive disclosure rather than disclosing too little.
If an author is aware that his or her institution has a financial relationship with a manufacturer that has an interest in the subject of his or her manuscript, the author needs to inform the Journal. The Journal does not require authors to make specific inquiries of the authorities of their institution.
After an article has been published, readers sometimes write to a journal because they have reason to believe that authors failed to disclose financial relationships with a manufacturer that has an interest in the subject of the article. The Journal will handle these inquiries according to the recommendation of the American Medical Association. Queries will be forwarded to authors, and authors will be required to provide a written explanation. New disclosures will be published in the correspondence columns of the Journal.
The Journal strongly opposes contractual agreements that deny investigators the right to examine data independently or to submit a manuscript for publication without first obtaining the consent of the sponsor. Researchers should not enter into agreements that interfere with their access to data or their ability to analyze data independently, to prepare manuscripts, and to publish them. Authors should describe the role of the study sponsor(s), if any, in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the report for publication. If the supporting source had no such involvement, the authors should so state. If a study is funded by an agency with a proprietary or financial interest in the outcome of the study, the corresponding author must include the following statement in the "Author Comments" area of the website: "I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis."
COMPANION PAPERS
The American Journal of Respiratory and Critical Care Medicine strongly discourages the submission of more than one manuscript dealing with related aspects of a single study. In almost every case, a single study is best reported in a single paper.
PRIOR AND FRAGMENTED PUBLICATION
The American Journal of Respiratory and Critical Care Medicine does not publish original contributions that contain a significant portion of material that has been published or submitted for publication elsewhere, with the exception of abstracts containing no more than 400 words. A computer search will be conducted to ensure that submissions have not been previously published. The Editors of the Journal reserve the right to determine what constitutes significant duplicate publication.
All manuscripts and data, submitted or in press, which are potentially overlapping, or related to, data presented in the submitted manuscript, must be appended to the online submission . With an online submission of a manuscript, state explicitly in the "Author Comments" area on the website that such material has been uploaded. When the data in the submitted manuscript potentially overlap with, or are related to, data presented in a previously published article or articles, the previously published article(s) need(s) to be listed in the "Author Comments" area on the website.
Some authors may see that two manuscripts overlap, but they consider the overlap insufficient to constitute duplicate publication. At the American Journal of Respiratory and Critical Care Medicine, we wish to make up our own mind as to whether the overlap is significant or not. No matter how small the overlap between two or more manuscripts, authors need to inform the Journal about the related work. If any of the control data in a manuscript are also included among the control data in another manuscript, the Journal must be informed. This requirement applies even when the results presented in the submitted manuscript do not overlap with the results presented in the other manuscript. When authors are in any doubt as to what material to enclose with a submitted manuscript, they should err on the side of including too much rather than too little.
A statement about overlap is best made in the Methods section of a manuscript. Alternatively, a statement can be made in the Online Repository even when no other material is being presented in the Repository. If for some reason neither of these options are suitable, a statement in the "Author Comments" area on the website will also be sufficient. On the Mandatory Submission Form, authors must state whether or not the submitted manuscript overlaps with another manuscript. Authors must also include a cross-reference in a submitted manuscript to potentially overlapping work. When authors develop doubts about possible duplication of publications after a manuscript has been submitted or has already been published, the Journal wants to be informed.
See the section on Redundant or Duplicate Publication in the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" at (http://www.icmje.org/index.htm). Authors should note the broad nature of expected disclosure. The Uniform Requirements contains the following statement, "The author should alert the editor if the work includes subjects about which a previous report has been published."
Authors do not need to attach abstracts with their submission when the abstracts are equivalent in length to an abstract submitted to the International Conference of the American Thoracic Society. If some or all of the work in the manuscript has been published or submitted in an abstract that exceeds 400 words, a copy must be attached to the online submission. An explanation of the nature of any possible overlap with the submitted manuscript must be placed in the "Author Comments" area on the website.
If some or all the research contained in a manuscript was previously published as one or more abstracts, irrespective of the number of words in the abstract, this point should be acknowledged in the last sentence of the Introduction. The recommended format is: "Some of the results of these studies have been previously reported in the form of an abstract (s) (References)." In addition, the abstract(s) must be listed in the references.
When authors are submitting a Review Article, the Journal wishes to be informed about other review articles that authors have published on a related topic. Review articles may contain previously published material such as illustrations or tables provided it is appropriately referenced. It is the responsibility of the author(s) to submit hard copies of appropriate written permission to utilize previously published material that would otherwise violate copyright regulations.
Authors who fail to follow the Journal's policy on the requirement for full disclosure of overlapping or related work may be banned from submitting manuscripts to the Journal for a period of time.
Editorial Board
|
Editor
MARTIN J. TOBIN, M.D.
Maywood, IL
Deputy Editors
AMAL JUBRAN, M.D.
Maywood, IL
PAUL O'BYRNE, M.D.
Hamilton, ON, Canada |
Associate Editors
STEVEN H. ABMAN, M.D.
Denver, CO
RICHARD K. ALBERT, M.D.
Denver, CO
PETER F. BARNES, M.D.
Tyler, TX
PETER J. BARNES, M.D., D.Sc.
London, United Kingdom
JOHN W. CHRISTMAN, M.D.
Nashville, TN
ROLAND M. du BOIS, M.D.
London, United Kingdom
LEONARDO M. FABBRI, M.D.
Modena, Italy
ALLISON D. FRYER, Ph.D.
Baltimore, MD
ROLF HUBMAYR, M.D.
Rochester, MN
ALLAN I. PACK, M.D., Ph.D.
Philadelphia, PA
SUSAN REDLINE, M.D., M.P.H.
Cleveland, OH
PETER D. SLY, M.D.
Perth, Australia
ANTHONY F. SUFFREDINI, M.D.
Bethesda, MD
SCOTT WEISS, M.D.
Boston, MA |
Peer Review Office
(Non-technical Questions Concerning Manuscript Submissions)
ATS Peer Review Office
Martin J. Tobin, M.D., Editor
American Journal of
Respiratory and Critical Care Medicine
61 Broadway
New York, NY 10006-2755
Manager
(Technical Questions Concerning Manuscript Submissions)
Helene Friedman
Tel: (212) 315-8625
Fax: (212) 315-8613
Peer Review Technical Support and Database Analyst
Fay Ling
Editorial Production Office
ATS Editorial Office
61 Broadway
New York, NY 10006-2755
Tel: (212) 315-6440
Fax: (212) 315-6455
Internet: http://www.thoracic.org
Managing Editor
Christina Shepherd
Editorial Production
Eric Gumpert
Sheila Higgins
Andrew Elder
Business Affairs
Donald E. Temple
Membership & Subscription
Jeffrey Delgado
Advertising Representative
Cunningham Associates
180 Old Tappan Road
Old Tappan, NJ 07675
Tel: (201) 767-4170
Fax: (201) 767-8065 |
|
|
Editoral Board
|
|
|
ROBYN J. BARST, M.D.
New York, NY
JASON H.T. BATES, Ph.D.
Burlington, VT
WILLIAM S. BECKETT, M.D., M.P.H.
Rochester, NY
ELISABETH H.D. BEL, M.D., Ph.D.
Leiden, The Netherlands
FRAN荗IS BELLEMARE, Ph.D.
Montreal, PQ, Canada
ANDREW BERSTEN, M.D.
Adelaide, Australia
T. DOUGLAS BRADLEY, M.D.
Toronto, ON, Canada
LAURENT BROCHARD, M.D.
Creteil, France
CHRISTIAN BRUN-BUISSON, M.D.
Creteil, France
WILLIAM J. CALHOUN, M.D.
Pittsburgh, PA
PETER M. CALVERLY, M.D.
Liverpool, United Kingdom
RICHARD CASABURI, Ph.D., M.D.
Torrance, CA
KIAN FAN CHUNG, M.D., D.Sc.
London, United Kingdom
DONALD W. COCKCROFT, M.D.
Saskatoon, SK, Canada
GENE L. COLICE, M.D.
Washington, D.C.
DONALD E. CRAVEN, M.D.
Burlington, MA
CHARLES L. DALEY, M.D.
San Francisco, CA
ANDR?DE TROYER, M.D.
Brussels, Belgium
NEIL J. DOUGLAS, M.D.
Edinburgh, United Kingdom
JEFFREY DRAZEN, M.D.
Boston, MA
DIDIER D. DREYFUSS, M.D.
Columbes, France
ALI EL-SOLH, M.D., M.P.H.
Buffalo, NY
PIERRE-PAUL ERNST, M.D., M.Sc.
Montreal, PQ, Canada
MARC ESTENNE, M.D.
Brussels, Belgium
TIMOTHY W. EVANS, M.D., Ph.D.
London, United Kingdom
PATRICK J. FAHEY, M.D.
Maywood, IL |
ALAN M. FEIN, M.D.
Manhasset, NY
HENRY F. FESSLER, M.D.
Baltimore, MD
BENJAMIN M. GASTON, M.D.
Charlottesville, VA
SIMON GODFREY, M.D., Ph.D.
Jerusalem, Israel
BRYDON J.B. GRANT, M.D.
Buffalo, NY
NICHOLAS J. GROSS, M.D., Ph.D.
Hines, IL
JESSE HALL, M.D.
Chicago, IL
JOHN E. HEFFNER, M.D.
Charleston, SC
NICHOLAS S. HILL, M.D.
Boston, MA
FREDERIC HOPPIN, M.D.
Pawtucket, RI
DAVID B. JACOBY, M.D.
Baltimore, MD
ALAN JOBE, M.D., Ph.D.
Cincinnati, OH
ANNA-LUISE KATZENSTEIN, M.D.
Syracuse, NY
FRANCINE KAUFFMANN, M.D.
Villejuif, France
BRIAN P. KAVANAGH, M.B.
Toronto, ON, Canada
KIERAN J. KILLIAN, M.B., B.Ch.
Hamilton, ON, Canada
TALMADGE E. KING, Jr., M.D.
San Francisco, CA
JOHAN KIPS, M.D., Ph.D.
Ghent, Belgium
FRANCO LAGHI, M.D.
Hines, IL
ROBERT F. LODATO, M.D.
Houston, TX
MAURIZIO LUISETTI , M.D.
Pavia, Italy
JORDI MANCEBO, M.D.
Barcelona, Spain
FERNANDO J. MARTINEZ, M.D.
Ann Arbor, MI
MICHAEL MATTHAY, M.D.
San Francisco, CA
DICK MENZIES, M.D.
Montreal, PQ, Canada
DAVID G. MORRIS, M.D.
New Haven, CT
MICHAEL NIEDERMAN, M.D.
Mineola, NY
RICHARD J. O'BRIEN, M.D.
Atlanta, GA
MICHAEL R. PINSKY, M.D.
Pittsburgh, PA |
DIDIER PITTET, M.D
Geneva, Switzerland
JEAN-FRANCOIS PITTET, M.D.
San Francisco, CA
MICHAEL B. REID, Ph.D.
Houston, TX
JEAN-JACQUES ROUBY, M.D., Ph.D.
Paris, France
LEWIS J. RUBIN, M.D.
La Jolla, CA
MARINA SAETTA, M.D.
Padua, Italy
JONATHAN M. SAMET, M.D.
Baltimore, MD
MARK H. SANDERS, M.D.
Pittsburgh, PA
SCHERER P. SANDERS, Ph.D.
Baltimore, MD
GREGORY SCHMIDT, M.D.
Chicago, IL
STEPHANIE SHORE, Ph.D.
Boston, MA
GARY C. SIECK, Ph.D.
Rochester, MN
SHAWN J. SKERRETT, M.D.
Seattle, WA
PETER STERK, M.D., Ph.D.
Leiden, The Netherlands
JACOB I. SZNAJDER, M.D.
Chicago, IL
ANNE TATTERSFIELD, M.D.
Nottingham, United Kingdom
THEODOROS VASSILAKOPOULOS, M.D.
Athens, Greece
PETER D. WAGNER, M.D.
La Jolla, CA
KEITH R. WALLEY, M.D.
Vancouver, BC, Canada
E. HAYDN WALTERS, M.D.
Hobart, Tas., Australia
ADAM WANNER, M.D.
Miami, FL
LORRAINE B. WARE, M.D,
Nashville, TN
JADWIGA A. WEDZICHA, M.D.
London, England
IDELLE M. WEISMAN, M.D.
El Paso, TX
ANTHOL WELLS, M.D.
London, England
SALLY E. WENZEL, M.D.
Denver, CO
DAVID WHITE, M.D.
Boston, MA
MAGDY YOUNES, M.D.
Winnipeg, MB, Canada |
|
刊名字顺( Alphabetical List of Journals):
返回页首 